SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2669VELCADE(R) (Bortezomib) for Injection Showed Unprecedented Results In Newly DiagIan@SI-6/21/2006
266806:07 ET Data from Cytogen's phase 1 clinical trial of QUADRAMET in patientsIan@SI-6/19/2006
2667[Comparative Selectivity and Specificity of the Proteasome Inhibitors BzLLLCOCHOtuck-6/18/2006
2666The offer from a third party has put them in "play". If the price is rGuy Gadois-6/15/2006
2665Trading resumes. Most of the Faber erroneous report has gone to money heaven. Ian@SI-6/15/2006
2664Millennium Responds to Market Report 14:21 EDT Thursday, June 15, 2006 CAMBIan@SI-6/15/2006
2663Looks like MLNM has been halted since 2:09 Haven't seen anything from any sIan@SI-6/15/2006
2662mlnm just announced they were putting themselves "up for sale.." - perLJM-6/15/2006
2661Lehman Ups Millennium Pharma To Overweight >MLNM DOW JONES NEWSWIRES June 14Ian@SI-6/14/2006
2660Millennium Files sNDA for VELCADE(R) (Bortezomib) for Injection in Treatment of Icebrg-6/9/2006
2659Frequency, Characteristics, and Reversibility of Peripheral Neuropathy During TrIcebrg-6/8/2006
2658Addition of <b>VELCADE(R) (Bortezomib) for Injection Improved survival in Ian@SI-6/4/2006
2657VELCADE(R) (Bortezomib) for Injection May Offer New Standard of Care in RelapsedIan@SI-6/4/2006
2656VELCADE(R) (Bortezomib) for Injection Demonstrated High Single-Agent Response RaIan@SI-6/4/2006
2655[Proteasome inhibitors induce death but activate NF-kappa B on endometrial carcituck-6/2/2006
2654Merrill: MLN1202 hits primary endpoint of reducing CRP MLNM announced positive tom pope-6/1/2006
2653I re-entered the stock today on the news - I'd been meaning to do so for a lsjemmeri-5/31/2006
2652A bit of somewhat unexpected good news. Have all MLNM's fan deserted it???Ian@SI-5/31/2006
2651<NPI-0052 was discovered during the fermentation of Salinispora sp, a new claMike McFarland-5/29/2006
2650>>New Data on VELCADE(R) (bortezomib) for Injection to be Presented at Upctuck-5/26/2006
2649Nereus' anticancer drug begins human testing 16th May 2006 By Tom Neilson NeIcebrg-5/17/2006
2648SOUTH SAN FRANCISCO, Calif., May 11 /PRNewswire-FirstCall/ -- Genentech, Inc. (NIcebrg-5/12/2006
2647The Combination of the Proteasome Inhibitor Bortezomib and the Bcl-2 Antisense MIcebrg-5/7/2006
2646Acute Coronary Syndrome Deaths Decline If Hospitals Follow Guidelines By JudithIcebrg-4/29/2006
2645Is any Leerink-Swann upgrade a good thing? or is MLNM just being damned with fIan@SI-4/24/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News